Back to NVAX Stock Lookup

Novavax (NVAX) – Company Press Releases

Jul 6, 2021 08:30 AM Novavax to Host Conference Call to Discuss Second Quarter Financial Results and Operational Highlights on August 5, 2021
Jun 30, 2021 05:26 PM Novavax Publishes Results of United Kingdom Phase 3 Clinical Trial in New England Journal of Medicine, Demonstrating High Levels of Efficacy of COVID-19 Vaccine
Jun 17, 2021 04:02 PM Novavax to Participate in Fireside Chat at SVB Leerink CybeRx Series: Vaccine Forum
Jun 17, 2021 09:22 AM Novavax to Participate in National Vaccine Advisory Committee Meeting
Jun 14, 2021 04:05 PM Novavax Announces Positive Results from First Study of Influenza Vaccine and COVID-19 Vaccine Candidate Administered Simultaneously
Jun 14, 2021 06:00 AM Novavax COVID-19 Vaccine Demonstrates 90% Overall Efficacy and 100% Protection Against Moderate and Severe Disease in PREVENT-19 Phase 3 Trial
Jun 11, 2021 04:05 PM Novavax Announces Positive Data from Three Complementary Studies of COVID-19 Beta (B.1.351) Variant Strain Vaccine
Jun 9, 2021 09:03 AM Novavax to Host Maryland Governor Larry Hogan at Site of Future Novavax Vaccines Innovation Campus and Global Headquarters
Jun 7, 2021 04:05 PM Novavax to Participate in Panel at BIO Digital 2021
May 27, 2021 08:30 AM Novavax to Participate in Jefferies Virtual Healthcare Conference
May 24, 2021 05:03 PM Novavax to Present at International Society for Vaccines Virtual Congress COVID-19 Vaccine Update
May 22, 2021 12:20 PM Novavax Announces Memorandum of Understanding to Explore Expansion of COVID-19 Vaccine Activities in South Korea
May 21, 2021 08:53 AM Novavax Honored by Maryland Tech Council During 2021 Industry Awards Celebration
May 10, 2021 04:02 PM Novavax Reports First Quarter 2021 Financial Results and Operational Highlights
May 10, 2021 09:12 AM Novavax Announces Positive Preclinical Data for Combination Influenza and COVID-19 Vaccine Candidate
May 6, 2021 09:05 AM Novavax and Gavi Execute Advance Purchase Agreement for COVID-19 Vaccine for COVAX Facility
May 5, 2021 05:03 PM New England Journal of Medicine Publishes Phase 2b Clinical Trial Results Demonstrating Efficacy of Novavax COVID-19 Vaccine Against the B.1.351 Variant
May 3, 2021 08:51 AM Novavax Initiates Pediatric Expansion for Phase 3 Clinical Trial of COVID-19 Vaccine
Apr 23, 2021 04:02 PM Novavax to Host Conference Call to Discuss First Quarter Financial Results and Operational Highlights on May 10, 2021
Apr 23, 2021 05:00 AM Malaria Vaccine Phase 2b Clinical Trial Results Published in Preprints with The Lancet
Apr 14, 2021 05:39 PM Novavax to Participate in University of Oxford Com-COV2 Study Comparing Mixed COVID-19 Vaccine Combinations
Apr 13, 2021 05:34 PM Novavax Announces Leadership Updates
Apr 5, 2021 04:05 PM Novavax Initiates COVID-19 Vaccine Clinical Trial Crossover
Apr 5, 2021 08:50 AM Novavax CEO Stan Erck to Participate in Longwood Healthcare Leaders Meeting
Mar 29, 2021 04:02 PM GSK to support manufacture of Novavax' COVID-19 vaccine
Mar 11, 2021 04:02 PM Novavax Confirms High Levels of Efficacy Against Original and Variant COVID-19 Strains in United Kingdom and South Africa Trials
Mar 8, 2021 06:00 PM Novavax to Participate in H.C. Wainwright Virtual Global Life Sciences Conference Fireside Chat
Mar 1, 2021 04:02 PM Novavax Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Highlights
Feb 26, 2021 08:22 AM Novavax and Takeda Finalize License Agreement for Novavax’ COVID-19 Vaccine Candidate in Japan; Takeda Initiates Phase 1/2 Trial in Japan
Feb 26, 2021 08:22 AM Novavax and Takeda Finalize License Agreement for Novavax’ COVID-19 Vaccine Candidate in Japan; Takeda Initiates Phase 1/2 Trial in Japan
Feb 22, 2021 07:00 AM Novavax Completes Enrollment of PREVENT-19, COVID-19 Vaccine Pivotal Phase 3 Trial in the United States and Mexico
Feb 22, 2021 07:00 AM Novavax Completes Enrollment of PREVENT-19, COVID-19 Vaccine Pivotal Phase 3 Trial in the United States and Mexico
Feb 18, 2021 04:02 PM Novavax Announces Memorandum of Understanding with Gavi for Cumulative Supply to COVAX Facility of 1.1 Billion Doses of COVID-19 Vaccine
Feb 18, 2021 04:02 PM Novavax Announces Memorandum of Understanding with Gavi for Cumulative Supply to COVAX Facility of 1.1 Billion Doses of COVID-19 Vaccine
Feb 16, 2021 08:00 AM Novavax to Host Conference Call to Discuss Fourth Quarter Financial Results and Operational Highlights on March 1, 2021
Feb 15, 2021 08:04 PM Novavax Announces Expanded Collaboration and License Agreement with SK Bioscience for 40 Million Doses of COVID-19 Vaccine for South Korea
Feb 15, 2021 08:04 PM Novavax Announces Expanded Collaboration and License Agreement with SK Bioscience for 40 Million Doses of COVID-19 Vaccine for South Korea
Feb 4, 2021 04:05 PM Novavax Announces Start of Rolling Review by Multiple Regulatory Authorities for COVID-19 Vaccine Authorization
Feb 4, 2021 04:05 PM Novavax Announces Start of Rolling Review by Multiple Regulatory Authorities for COVID-19 Vaccine Authorization
Feb 3, 2021 09:14 PM Novavax and Government of Switzerland Announce Agreement in Principle to Supply COVID-19 Vaccine
Feb 2, 2021 12:31 PM Novavax Announces Memorandum of Understanding to Produce COVID-19 Vaccine Made in Canada
Feb 1, 2021 07:32 PM Novavax to Present COVID-19 Vaccine Candidate Data at New York Academy of Science
Jan 28, 2021 04:05 PM Novavax COVID-19 Vaccine Demonstrates 89.3% Efficacy in UK Phase 3 Trial
Jan 28, 2021 04:05 PM Novavax COVID-19 Vaccine Demonstrates 89.3% Efficacy in UK Phase 3 Trial
Jan 22, 2021 05:22 PM Novavax and Government of Canada Finalize Advance Purchase Agreement for COVID-19 Vaccine
Jan 22, 2021 05:22 PM Novavax and Government of Canada Finalize Advance Purchase Agreement for COVID-19 Vaccine
Jan 22, 2021 04:49 PM Novavax Names Madelyn Caltabiano Senior Vice President, Global Program Management
Jan 15, 2021 08:00 AM Regulatory Expert Henrietta Ukwu, M.D. Appointed Novavax Chief Regulatory and Quality Officer
Jan 15, 2021 08:00 AM Regulatory Expert Henrietta Ukwu, M.D. Appointed Novavax Chief Regulatory and Quality Officer
Jan 7, 2021 06:14 PM Novavax Finalizes Agreement with Commonwealth of Australia for 51 Million Doses of COVID-19 Vaccine

Back to NVAX Stock Lookup